Acquired TPM3-NTRK1 fusion resistant to larotrectinib in a non-small cell lung cancer with EML4-ALK fusion progressed on lorlatinibHoryun Choi,Jinah Kim,Yeun Ho Lee,Leeseul Kim,Na Hyun Kim,Young Kwang ChaeCANCER RESEARCH(2022)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要